NASDAQ, INC.

NASDAQ, INC. (NDAQ) — Investment Memo

🐂 The Bull Case (Warren’s voice)

• Moat is real and sticky. Listing on NASDAQ is a pain to reverse; data feeds are proprietary; Adenza’s regulatory software locks clients into multi‑year contracts. These switching costs create a floor under revenue, even in mediocre years.
• Recurring revenue dominates. Capital Access Platforms (listing fees, data subscriptions) and Financial Technology (software licenses) are >60% of revenue and highly predictable. Market Services is volatile but acts as a volume‑driven kicker.
• FCF consistently exceeds net income — a rare mark of conservative accounting. FCF CAGR of 12.8% (2016‑2025) means the business genuinely generates cash, not just accounting profits.
• The economic moat is regulatory + IP. You cannot replicate an SEC‑regulated exchange overnight. NASDAQ’s brand and data are monopolistic for its own listings.
• At a deep discount — say, <$80/share (25% below DCF) — the debt fears are already priced in, and the switching‑cost moat provides a survivable floor. If management delevers over 3–5 years, ROE could recover to 18%+. That’s a double‑digit compounding story.

🐻 The Bear Case (Charlie inverts)

“Invert, always invert.” The 3 permanent impairment scenarios:

1. The debt noose tightens in a recession. $8.6B debt (D/E 0.70x) is manageable today but crushing if trading volumes halve and software subscriptions pause. Interest coverage could drop below 2x, forcing asset sales or equity dilution. This is not a temporary dip — it’s a structural destruction of equity if covenants are tripped.

2. Technology disruption of the switching‑cost moat. A cloud‑native, API‑based exchange or trade‑management system (e.g., from a fintech like CBOE’s digital platform or a startup) could undercut NASDAQ’s data feeds and software lock‑in. Once a client’s data is portable, the switching cost evaporates. This is a 5–10 year threat, but it’s permanent — NASDAQ’s historic advantages are rooted in proprietary systems, not innovation.

3. Adenza integration failure. The $10.5B acquisition has not yet delivered the promised ROE recovery (18% pre‑deal → 14.6% in 2025, still below). If synergy targets are missed, goodwill impairment ($12B+ on the balance sheet) could erase equity value. The debt load means there’s no room for error.

Most likely scenario over 3–5 years: Slow‑bleed from fee compression (Market Services net yield declining) + debt overhang that limits buybacks and investment → ROE stagnates at ~12‑14%, and the stock lacks catalysts, trading below intrinsic value for years. Damage is not catastrophic but painful — a lost decade for shareholders.

💰 Valuation & Margin of Safety

• DCF intrinsic value: $60.7B total / $106.57 per share (12.8% FCF growth, 10% discount rate, 3% terminal). This is the base case — but we question the growth assumption given debt and moat narrowing.
• 25% margin of safety entry: $79.93/share — conservative, discounts integration risk and recession fear.
• 50% margin of safety (Buffett’s ideal): $53.29/share — only at this price does the balance sheet risk become a compensated gamble.
• Current market price: Not provided. If at or above $106.57, it’s expensive (no margin against the bear scenarios). If below $80, it’s fair but not a “sure thing.” Only below $53 does it approach Berkshire’s circle of competence.

Verdict: PASS

At intrinsic value of $106.57, the current price offers no margin of safety against a leveraged balance sheet and a narrowing moat. We require a 50% discount to $53 to compensate for the risk of permanent impairment from debt, technology disruption, or integration failure — and the DCF itself assumes optimistic growth. This business is not the kind of certainty Buffett buys; it’s a watch‑list candidate for a better price and a cleaner balance sheet.